PUBLICATIONS & TRAINING
Publications 2011-2013:
Journal articles (peer reviewed)
1. Langerak NG, Du Toit J, Burger M, Cotton MF, Springer PE, Laughton B. Spastic diplegia in children with HIV encephalopathy: first description of gait and physical status. Developmental Medicine and Child Neurology 2013 PMID: 24182356
2. Cotton MF, Violari A, Otwombe K, Panchia R, Handelsman E, et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial; Lancet 2013 PMID:24209829
3. Pitcher R, Lombard C, Cotton MF, Beningfield S and Zar H. Clinical and Immunological Correlates of Chest X-Ray Abnormalities in HIV-Infected South African Children With Limited Access to Anti-Retroviral Therapy. Pediatr Pulmonol; 2013 PMID: 23970463
4. Weber HC, Gie RP and Cotton MF. The challenge of chronic lung disease in HIV-infected children and Adolescents. Int J Tuberc Lung Dis 2013, 16:18633 PMID:23782483
5. E Kalk, A Slogrove, D P Speert, J A Bettinger, M F Cotton, M Esser. HIV seroconversion during late pregnancy – when to retest. S Afr J HIV Med 2013; 14(2):90-92.
6. Vanden Driessche K, Marais BJ, Wattenberg M, et al. The Cough Cylinder: a tool to study measures against airborne spread of (myco-) bacteria. Int J Tuberc Lung Dis 2013; 17(1): 46-53. PMID:23232004
7. Prendergast AJ, Penazzato M, Cotton MF, et al. Treatment of young children with HIV infection: using evidence to inform policymakers. PLoS Med 2012; 9(7): e1001273. PMID:22910874
8. Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Cochrane Database Syst Rev 2012; 7: CD004772. PMID:22786492
9. Walters E, Reichmuth K, Dramowski A, Marais BJ, Cotton MF, Rabie H. Antiretroviral Regimens Containing a Single Protease Inhibitor Increase Risk of Virologic Failure in Young HIV-Infected Children Pediatr Infect Dis J 2013, 32 (4): 361-3 PMID:23114373
10. Mandalakas AM, Van Wyk S, Kirchner HL, Walzl G, Cotton M, Rabie H, Kriel B, Gie RP, Schaaf HS, Hesseling AC. Detecting Tuberculosis Infection in HIV-Infected Children: A Study of Diagnostic Accuracy, Confounding and Interaction. Pediatr Infect Dis J 2012 PMID:23190784
11. Cotton MF, Marais B, Andersson M, Eley B, Rabie H, Slogrove A, Dramowski A, Schaaf HS and Methar S: Commentary: minimizing the risk of non-vertical, non-sexual HIV infection in children – beyond mother to child transmission. JIAIS 2012, 15:17377. PMID:23199798; PMCID:PMC3500456
12. Slogrove A, Reikie B, Naidoo S, De Beer C, Cotton MF, et al: HIV-exposed infected infants are at increased risk in the first year of life. J Trop Paediatr 2012, 58(6) : 505-508. PMCID:PMC3612013
13. Nachega JB, Uthman OA, Anderson J, Pletzer K, Wampold S, Cotton MF, Mills EJ, Ho Y, et al: Adherence to antiretroviral therapy during and after pregancy in low-income, middle-income and high-income countries: a systematic review and meta-analysis. AIDS 2012, 26:2039-2052. PMID:22951634
14. Innes S, Cotton MF, Haubrich R, Conradie MM, et al: High prevalence of Lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study. BMC Pediatrics 2012; 12 : 1-19 PMCID:PMC3584923
15. Wiseman CA, Gie RP, Starke JR, Schaaf HS, Donald PR, Cotton MF, Hesseling AC: A proposed comprehensive classification of tuberculosis disease severity in children. The Pediatric Infectious Disease Journal 2012, 31(4):347-352. Cited by 1; IF 3.577
16. Violari A, Lindsey JC, Hughes MD, Mujuru HA, Barlow-Mosha L, Kamthunzi P, Chi BH, Cotton MF, Moultrie H, Khadse S et al: Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. The New England journal of medicine 2012, 366(25):2380-2389. IF 53.298
17. Smit L, Dramaowsky A, Clarke K, Clayton J, Scherer A, Slogrove A, Musvosvi H, Rifkin M, Cotton M, F.: Breaking the cycle: challenges and solutions in HIV policy. In: Protecting childhood in the AIDS pandemic: finding solutions that work. edn. Edited by Heymann J, Sherr L, Kidnan R. Oxford: Oxford University Press; 2012.
18. Laughton B, Cornell M, Grove D, Kidd M, Springer PE, Dobbels E, Rensburg AJ, Violari A, Babiker AG, Madhi SA, Cotton MF et al: Early antiretroviral therapy improves neurodevelopmental outcomes in infants. Aids 2012. IF 6.245
19. Kiser JJ, Zhu R, D'Argenio D Z, Cotton MF, Bobat R, McSherry GD, Madhi SA, Carey VJ, Seifart HI, Werely CJ et al: Isoniazid Pharmacokinetics, Pharmacodynamics, and Dosing in South African Infants. Ther Drug Monit 2012. IF 2.491
20. Holgate SL, Rabie H, Smith P, Cotton MF: Trough Lopinavir Concentrations in Preterm HIV-infected Infants. The Pediatric Infectious Disease Journal 2012, 31(6):602-604. IF 3.577
21. Holgate SL, Bekker A, Rabie H, Cotton MF: Oseltamivir use in low-birth weight infants during the 2009 nH1N1 influenza a outbreak in the Western Cape, South Africa. Journal of tropical pediatrics 2012, 58(2):102-106. IF 1.388
22. Hesseling AC, Kim S, Madhi S, Nachman S, Schaaf HS, Violari A, Victor TC, McSherry G, Mitchell C, Cotton MF: High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012, 16(2):192-195. IF IF 2.731
23. Heidari S, Mofenson LM, Hobbs CV, Cotton MF, Marlink R, Katabira E: Unresolved Antiretroviral Treatment Management Issues in HIV-Infected Children. Journal of acquired immune deficiency syndromes 2012, 59(2):161-169. IF 4.425
24. Cuevas LE, Browning R, Bossuyt P, Casenghi M, Cotton MF, Cruz AT, Dodd LE, Drobniewski F, Gale M, Graham SM et al: Evaluation of Tuberculosis Diagnostics in Children: 2. Methodological Issues for Conducting and Reporting Research Evaluations of Tuberculosis Diagnostics for Intrathoracic Tuberculosis in Children. Consensus From an Expert Panel. The Journal of infectious diseases 2012. Cited by 5; IF 6.410
25. Cotton MF, Rabie H: Group B streptococcal disease in infants. Lancet 2012. IF 38.278
26. Bekker A, Preez KD, Schaaf HS, Cotton MF, Hesseling AC: High tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012. IF 2.731
27. Wiseman CA, Schaaf HS, Cotton MF, Gie RP, Jennings T, Whitelaw A, Roux P, Hesseling AC: Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival. Int J Tuberc Lung Dis 2011, 15(6):770-775. Cited by 7; IF 2.731
28. van Zyl GU, Rabie H, Nuttall JJ, Cotton MF: It is time to consider third-line options in antiretroviral-experienced paediatric patients? J Int AIDS Soc 2011, 14:55. IF 3.256
29. Slogrove A, Rabie H, Cotton M: Paediatric Antiretroviral Drug Targets. Infect Disord Drug Targets 2011. Cited by 1
30. Sharland M, Luck S, Griffiths P, Cotton M: Antiviral therapy of CMV disease in children. Adv Exp Med Biol 2011, 697:243-260. Cited by 1; IF 1.093
31. Schubert PT, Cotton MF, Wright CA: Cytomorphological patterns of M. bovis BCG and M. tuberculosis on fine needle aspiration biopsies: Does HIV make a difference? Diagn Cytopathol 2011, 39(4):264-269. Cited by 1; IF 1.160
32. Rabie H, Violari A, Duong T, Madhi SA, Josipovic D, Innes S, Dobbels E, Lazarus E, Panchia R, Babiker AG et al: Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis. The International Journal of Tuberculosis and Lung Disease 2011, 15(9):1194-1200. Cited by 2; IF 2.731
33. Papasavvas E, Azzoni L, Foulkes A, Violari A, Cotton MF, Pistilli M, Reynolds G, Yin X, Glencross DK, Stevens WS et al: Increased Microbial Translocation in </=180 Days Old Perinatally Human Immunodeficiency Virus-Positive Infants as Compared With Human Immunodeficiency Virus-exposed Uninfected Infants of Similar Age. The Pediatric Infectious Disease Journal 2011. Cited by 2; IF 3.577
34. O'Connell N, Freeman N, Rabie H, Cotton MF: Presumed Cytomegalovirus Retinitis in Human Immunodeficiency Virus Type I-Infected South African Children. The Pediatric infectious disease journal 2011. IF 3.577
35. Mugabo P, Els I, Smith J, Rabie H, Smith P, Mirochnick M, Steyn W, Hall D, Madsen R, Cotton MF: Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2011, 101(9):655-658. Cited by 3; IF 2.042
36. McIlleron H, Ren Y, Nuttall J, Fairlie L, Rabie H, Cotton M, Eley B, Meyers T, Smith PJ, Merry C et al: Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antiviral therapy 2011, 16(3):417-421. Cited by 7; IF 3.161
37. Maritz ER, Kidd M, Cotton MF: Premasticating Food for Weaning African Infants: A Possible Vehicle for Transmission of HIV. Pediatrics 2011. Cited by 1; IF 5.437
38. Marais BJ, Rabie H, Cotton MF: TB and HIV in children advances in prevention and management. Paediatric Respiratory Reviews 2011, 12:39-45. Cited by 14; IF 2.197
39. Madhi SA, Violari A, Klugman KP, Lin G, McIntyre JA, von Gottberg A, Jean-Philippe P, Cotton MF, Adrian P: Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization. Vaccine 2011, 29(40):6994-7001. Cited by 5; IF 3.766
40. Madhi SA, Nachman S, Violari A, Kim S, Cotton M, F., Bobat R, Jean-Philippe P, McSherry G, Mitchell C: Effect of primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Eng J Med 2011, 365(1):21-31. Cited by 12; IF 53.298
41. le Roux DM, Cotton MF, le Roux SM, Whitelaw A, Lombard CJ, Zar HJ: Bacteremia in Human Immunodeficiency Virus-infected Children in Cape Town, South Africa. The Pediatric Infectious Disease Journal 2011:1. IF 3.577
42. Jaspan HB, Myer L, Madhi SA, Violari A, Gibb DM, Stevens WS, Dobbels E, Cotton MF: Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study. BMC pediatrics 2011, 11(1):104. IF 1.885
43. Innes S, Cotton M, F., Venter F: Why should we still care about the stavudine dose? South African Journal of HIV Medicine 2011(42):14-15. Cited by 2; IF 0.195
44. Holgate SL, Bekker A, Rabie H, Cotton MF: Oseltamivir Use in Low-Birth Weight Infants During the 2009 nH1N1 Influenza A Outbreak in the Western Cape, South Africa. Journal of tropical pediatrics 2011. IF 1.388
45. Heidari S, Mofenson L, Cotton M, F., Marlink R, Cahn P, Katabira E: Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children. J Acquir Immune Defic Syndr 2011, 57(4). Cited by 6; IF 4.425
46. Hainline C, Taliep R, Sorour G, Nachman S, Rabie H, Dobbels E, van Rensburg AJ, Cornell M, Violari A, Madhi SA et al: Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. BMC Res Notes 2011, 4:448.
47. Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ: The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax 2011. Cited by 4; IF 6.840
48. Dramowski A, Bekker A, Kirsten G, Marais BJ, Rabie H, Cotton MF: A case of congenital measles during the 2010 South African epidemic. Annals of tropical paediatrics 2011, 31(2):185-188. IF 1.388
49. Abrams AL, Opiyu N, Cotton M, F., Crowley S, Okebe J, Wisonge CS: Supporting registration of child-focused clinical trials in Africa: The Child Strategy project. S Afr Med J 2011, 101(11):804. IF 2.042
Weekly Training Sessions at KID CRU:
We have weekly training sessions that cover every occupation class here at KID CRU. This occurs every thursday afternoon at 2pm. The presenter leads a short presentation and then a variety of topics are discussed.
